NCT05623111View on ClinicalTrials.gov

Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

February 1, 2026

Conditions
Diabetic Neuropathy, Painful
Interventions
DRUG

Incobotulinumtoxin-A 100 UNIT Injection

Perineural injection

DRUG

Saline

Placebo containing trace amounts of human albumin and sucrose, diluted with 5ml of sterile saline.

Trial Locations (1)

2600

RECRUITING

Rigshospitalet Glostrup, Glostrup Municipality

Sponsors

Collaborators (1)

Merz Pharmaceuticals GmbH
All Listed Sponsors
collaborator

Merz Pharmaceuticals GmbH

INDUSTRY

collaborator

Toyota Foundation Denmark

UNKNOWN

collaborator

Steno Diabetes Center Zealand Region

UNKNOWN

collaborator

Shipwright Per Henriksen, R., and wife Foundation

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT05623111 - Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities | Biotech Hunter | Biotech Hunter